The current study aims to replicate the Bohus study published in 2013, comparing the effect of a 12-week residential DBT-PE program on the severity of PTSD to that of a waiting list condition in patients who suffer from CSA related PTSD and from oneā¦
ID
Source
Brief title
Condition
- Anxiety disorders and symptoms
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
KIP * Klinisch Interview PTSS/ CAPS - Clinical Administered PTSD Scale
We will use the Dutch version of the CAPS to measure the presence and severity
of PTSD. The CAPS is a semi-structured interview and consists of 30 items
concerning the frequency and severity of the PTSD Symptoms, associated features
and information about the onset and duration of the symptoms. The Dutch version
of de CAPS is called the KIP: Clinical Interview for PTSD. The KIP has a good
validity and a high interrater reliability, and is considered to be the gold
standard diagnosing PTSD. The KIP will be administered at T0, T1 and T2. It
will take about 90 minutes for the interview.
DTS - Davidson Trauma Scale
The Dutch version of the Davidson Trauma Scale will also be used to measure the
presence and severity of PTSD. It is a 17-item self-report measure that
assesses the 17 DSM IV symptoms of PTSD. Items are rated on a 5-point frequency
(not at all - every day) and severity scale (not at all distressing - extremely
stressing). Scores can also be calculated for each of the 3 PTSD symptom
clusters (National Center for PTSD). The scale demonstrated good test*retest
reliability and internal consistency. Concurrent validity was obtained against
the SCID. Good convergent and divergent validity was obtained. The DTS showed
predictive validity for response to treatment, as well as being sensitive to
treatment effects The DTS will be administered at T0, T1 and T2. It takes
about 10 minutes filling in the questionnaire at a computer.
Secondary outcome
SCID I * Structured Clinical Interview for DSM-IV Axis I Disorders
The SCID I will be used to diagnose axis I disorders. It is a semi structured
interview existing of 10 modules, representing axis I disorders, of which each
symptom can be scored with 1 till 3, or a *?* if it is unclear whether the
symptom is present. The interrater reliability is satisfying, provided that the
interviewers are trained. The SCID I will be administered at T0. The interview
takes about 60-90 minutes.
SCID-II - Structured Clinical Interview for DSM-IV axis II Personality
Disorders
Part of the SCID-II will be used to diagnose borderline personality disorder
(BPD). The SCID-II is a semi-structured DSM IV-based interview, examining the
presence of personality disorders. We will only use the part concerning BPD.
The SCID-II will be administered at T0 to differentiate between patients with
or without BPD. It will take about 10-30 minutes, depending on the presence of
BPD-criteria.
BPDSI * Borderline Personality Disorder Severity Interview
Bohus et al. (2013) used the Borderline Symptom List in their study, a
self-report measuring borderline symptoms. There is no Dutch version and no
comparable questionnaire with good psychometric data available in Netherlands.
Therefore we choose to use the BPDSI, a tool to determine the severity of
borderline personality disorder. The dimensional total score gives an
indication of the frequency and nature of the borderline symptoms during a
defined period. The reliability (0.93), and internal consistency (Cronbach's
alpha = 0.85) are good, concurrent and construct validity are excellent. The
BPDSI will be administered at T0, T1 and T2 only in the group that scored
positive with the SCID-II in the presence of BPD. The interview takes about 90
minutes. This interview is suitable to measure changes in borderline
symptomatology. Because the internal consistency of the subscales is good, we
can use the subscale *parasuicidal* to score non-suicidal self-injury (NSSI)
with this instrument.
DES * Dissociative Experience Scale
The Dutch version of the DES will be used to screen for dissociative
experiences. It consists of 28 questions which are scored on a Likert-scale
varying from 0% (never) till 100% (all the time). The reliability and validity
have been confirmed in several studies. The DES will be administered at T0, T1
and T2. It takes about 10 minutes to fill in the scale.
SCL *90 * Symptom Checklist 90
The Symptom Checklist 90 will be used to obtain information regarding symptom
severity on nine different subscales. The 90 items of the questionnaire are
scored on a five-point Likert scale, indicating the rate of occurrence of the
symptoms during the time reference. Internal consistencies have been good and
test-retest reliability has been adequate. The validity of the instrument is
controversial: some studies claim convergence to theoretically similar
constructs, most report a lack of sufficient discriminant validity. There is
strong support for the validity of the SCL *90 as a measure of general symptom
severity. The SCL*90 will be administered at T0, T1 and T2 and takes about 15
minutes to complete.
WSAS - Work and Social Adjustment Scale
The WSAS is a simple, reliable and valid measure of impaired functioning. It
contains of five items, inquiring into the level of impairment, due to the
disorder, on the domains of work, home management, social leisure activities
(visiting clubs, bars, parties, sports clubs), private leisure activities
(reading, gardening, listening to music) and maintaining close relationships.
Cronbach's * ranged from 0.70 to 0.94 and the test-retest reliability was 0.73.
The WSAS is sensitive to different levels of severity and to treatment-related
change (Mundt, 2002).
Tic-P
The questionnaire on healthcare consumption and productivity losses for
patients with a Psychiatric disorder (TiC-P) is a questionnaire focused on
establishing direct medical costs and productivity costs due to absence from
work and is widely used in the Netherlands for economic evaluations in mental
health (Bouwmans, 2013). The questionnaire has been shown to be a feasible and
reliable instrument to assess costs associated with care consumption and work
absence in patients with psychiatric disorders (Bouwmans, 2013).
EQ-5D
EQ-5D is a standardized instrument developed by the EuroQol Group as a measure
of health-related quality of life that can be used in a wide range of health
conditions and treatments. The descriptive system comprises five dimensions:
mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension can be rated at three levels: no problems, some problems and
major problems (Euroquol Group, 1990).
WAIS-IV
The WAIS-IV (Wechsler Adult Intelligence Scale * IV, Dutch version, Wechsler,
2009) is an instrument for clinical use to investigate cognitive performance in
adults (age 16+). The WAIS IV will be administered to all eligible patients
interested in participating in this trial. Patients with an IQ <70 as measured
by the WAIS IV, will be excluded from this trial, as intellectual disability is
one of the exclusion criteria. For psychometric properties, see James et al.
(James 2011).
REFERENCES
see the comprehensive study outline that is added as an Appendix
Background summary
BACKGROUND
Until only a few years ago, we had little to offer in terms of evidence based
treatment to those who suffer from the most severe consequences of childhood
sexual abuse (CSA), a combination of a posttraumatic stress disorder (PTSD) and
co-morbid conditions such as a borderline personality disorder (BPD) or
substance use disorder.
A history CSA is strongly associated with a substantial increase in the life
time risk of a variety of psychiatric disorders, including not only PTSD, but
also mood- and anxiety disorders, somatoform disorders, attention deficit
disorder, psychosis and schizophrenia, substance use disorders, suicidal
behaviour, deliberate self-harm and personality disorders.
Traditionally, treatment programs for patients with PTSD include stabilizing
interventions that are used to prepare patients with more severe forms of PTSD
for what is considered to be essential in the recovery from PTSD: exposure in
some form to trauma memories. For example, the ISTSS Expert Consensus
Guidelines for Complex PTSD propose a stepped model with three treatment
phases: 1. Stabilization and strengthening: patient safety, strengthening one*s
capacities for emotional awareness and expression, increasing positive
self-concept, addressing feelings of guilt and shame, and increase
interpersonal and social competencies. 2. Review and reappraisal of trauma
memories: re-experiencing traumatic events in the context of an actual and
subjectively experienced safe environment. 3. Consolidation of the gains of the
treatment so far.
Some experts have questioned this somewhat conservative approach to trauma
treatment. For example, some argue that there is no convincing empirical
evidence justifying the stabilization phase prior to an evidence-based trauma
treatment (EMDR of Trauma-focused cognitive behavioral therapy). In the
Netherlands, a number of experts have also suggested that trauma-focussed
therapy without a prior stabilisation phase is feasible and clinically
beneficial for patients with PTSD.
Especially in patients with a comorbid BPD, that may be characterized by
profound emotional instability, deliberate self-harm and suicidal behavior,
stability as a pre-treatment condition may be too much to ask for. Moreover,
often the symptoms and problems associated with the PTSD in turn complicate the
treatment of the personality disorder. With the two conditions complicating
and frustrating each other's treatment, therapists of victims of CSA had the
least to offer to those patients who needed it most, i.e., until recently.
In 2013, Martin Bohus and his co-workers from the Central Institute of Mental
Health in Mannheim published the results of a 12-week residential treatment
program that was specifically designed for patients with severe PTSD
complicated by comorbid conditions such as a BPD (Bohus 2013). The program
combines dialectical behavioral therapy (DBT), one of the best documented
interventions for BPD, with prolonged exposure (PE) to trauma memories (Steil
2011).
Bohus distinguishes three major challenges in the treatment of PTSD and
comorbid BPD that might interfere with the traditional treatment protocols for
PTSD. Firstly, patients with BPD are prone to exhibit emotional over-engagement
or severe dissociative symptoms during exposure. Secondly, the diversity of
trauma-related emotions and cognitions requires individualized, specific
interventions. Thirdly, the *complexity of multiple daily life problems*
referring to the problems PTSD-BPD patients often have with their daily hassles
because of their difficulties in social interaction, and their interference
with the therapeutic task. Bohus argues that, for the PTSD-BPD patients, a
modular programme that can be tailored to the actual needs of the patients is
better suited than a phase-based linear program, that often leads to early
dropout in this population.
Bohus et al. compared their intervention to a waiting list condition in a
single blind randomized design. The results of the Mannheim residential program
are very promising, with significant and clinically relevant changes in the
patient group that was randomized to the active condition, a large effect size
(a Hedges'g of 1.6), and little dropout. The treatment results on the PTSD
severity seem to be independent of severity of the personality disorder;
neither a diagnosis of BPD nor the severity of the number of BPD symptoms was
significantly related to treatment outcome.
One year earlier, in 2012, the research group of Marsha M. Linehan, founder of
DBT method, published the results of a similar combined DBT-PE treatment
program, however with a more linear design (Harned 2012). In this program, if
DBT leads to a complete disappearance of deliberate self-harm, patients are
allowed to start with prolonged exposure, while continuing with the DBT
programme. In contrast, in the Mannheim protocol, exposure starts, regardless
of the presence or absence of deliberate self-harm. Harned et al. also report
significant reductions in PTSD severity after treatment and no evidence for
exacerbations of deliberate self-harm.
Inspired by the promising results of the Mannheim program, GGZ Friesland
started a similar residential treatment program in Leeuwarden. The complete
staff of our department was trained by Martin Bohus before the first patients
were included in March 2014.
To date, there is only one published clinical trial, with less than a total of
80 randomized patients, to substantiate the claim of success of this new
intervention (Bohus 2013). It has been shown in numerous studies that the
results in first trials of new interventions are not necessarily replicated in
follow-up studies. Apart from publication bias that selects trials with
positive findings, the relation between effect and protocol adherence, the
effects of a particular psychological intervention may also be somewhat
dependent of the personal qualities of the founder and his or her team.
Implementation of the method by a different group, regardless of protocol
adherence, may not be as effective as the original one. To further solidify the
evidence base of this promising new method, follow-up studies are absolutely
necessary.
REFERENCES
Bohus, M., Dyer, A. S., Priebe, K., Kruger, A., Kleindienst, N., Schmahl, C.,
et al. (2013). Dialectical behaviour therapy for post-traumatic stress disorder
after childhood sexual abuse in patients with and without borderline
personality disorder: A randomised controlled trial. Psychotherapy and
Psychosomatics, 82(4), 221-233.
Harned, M. S., Korslund, K. E., Foa, E. B., & Linehan, M. M. (2012). Treating
PTSD in suicidal and self-injuring women with borderline personality disorder:
Development and preliminary evaluation of a dialectical behaviour therapy
prolonged exposure protocol. Behaviour Research and Therapy, 50(6), 381-386.
Steil, R., Dyer, A., Priebe, K., Kleindienst, N., & Bohus, M. (2011).
Dialectical behaviour therapy for posttraumatic stress disorder related to
childhood sexual abuse: A pilot study of an intensive residential treatment
program. Journal of Traumatic Stress, 24(1), 102-106.
Study objective
The current study aims to replicate the Bohus study published in 2013,
comparing the effect of a 12-week residential DBT-PE program on the severity of
PTSD to that of a waiting list condition in patients who suffer from CSA
related PTSD and from one or more comorbid conditions such as BPD.
Question 1) What is the effect of clinical DBT-PE on the severity of PTSD at 12
weeks from the start of the program?
Secondary questions are:
Question 2) Does the effect of clinical DBT-PE depend on the presence or
absence, or the severity of symptoms of a co-morbid borderline personality
disorder?
Question 3) What is the effect of clinical DBT-PE on the frequency of and urge
for non-suicidal self-injury (NSSI) and suicidal ideation?
Question 4) What is the effect of clinical DBT-PE on the severity of the
symptoms of borderline personality disorder?
Question 5) How stable are the effects of clinical DBT-PE after the clinical
treatment program has stopped?
Question 6) What is the effect of the clinical DBT-PE on social functioning?
Question 7) What is the incremental cost-effectiveness of clinical DBT-PE as
compared to a 5-year traditional ambulatory treatment?
Study design
We propose a single-blinded randomized controlled trial (RCT), comparing our
12-week clinical DBT-PE program to a 12-week waiting list condition (WL). In
this waiting list condition, participants are allowed to continue their current
treatment with the referring therapist, except for trauma therapy. The proposed
design and choice of effect parameters deliberately concur with those of the
trial published by Bohus et al. (Bohus 2013). It is in many respects a replica,
because we want to examine the generalizability of their results to a new
treatment centre (i.e., a different team in a different country). It is single
blinded in the sense that only the observers of the treatment effect will be
blinded for the treatment condition. The proposed duration of our WL condition
(12 weeks) accidentally approximates the current average waiting time for our
program. Thus, participation with the possibility of being randomized to WL
will not pose an extra burden on our patients, as far as waiting for treatment
is concerned. For the WL condition we schedule two evaluations, the first (T0)
before randomization, the second (T1) at 12 weeks. For the DBT-PE condition, we
add a third evaluation (T2) at 24 weeks in order to examine the stability of
the treatment effects (study question 5). The follow-up duration for the
participants randomized to the WL condition in our study will be limited to 12
weeks, in contrast to the 26 weeks in the Bohus trial. Bohus et al. (2013)
demonstrated that the symptom severity among patients in the WL condition
remains essentially unchanged during the 26 weeks of follow-up.
Bohus, M., Dyer, A. S., Priebe, K., Kruger, A., Kleindienst, N., Schmahl, C.,
et al. (2013). Dialectical behaviour therapy for post-traumatic stress disorder
after childhood sexual abuse in patients with and without borderline
personality disorder: A randomised controlled trial. Psychotherapy and
Psychosomatics, 82(4), 221-233.
Intervention
Dialectical behavioural therapy + prolonged exposure (DBT-PE): our clinical
DBT-PE program is very similar to the treatment program in Mannheim. Our team
has been fully trained in all details of the interventions by prof. Bohus
before we included our first patients. During the first year, our team was
supervised on a regular basis by prof. Bohus, to enhance protocol adherence.
The DBT-PE is a 12-week residential program with an intensive modular therapy
program that is specifically tailored to the individual patient. It consists of
individual treatment within a group setting; in addition to individual trauma
therapy there are numerous group modules that are targeted at increasing the
general coping skills of the participants. The program allows for a total of 25
individual psychotherapy sessions, lasting 60 minutes each.
There is a strong holding environment for the patient thanks to the 24-hour
care. The treatment entails three different phases. The first phase covers the
first three weeks during which patients prepare themselves for trauma therapy
by determining their individual goals during their therapy and learning skills
to regulate their arousal. During the second phase, from week 4 until week 9,
the focus is on skills-based prolonged exposure. Skills-based prolonged
exposure implies that patients use their skills to regulate their arousal
during the trauma therapy, allowing the patient to process his trauma. In the
last three weeks, the aim is to finalize processing of the trauma through
radical acceptance of the trauma as part of history with its consequences for
the future and the main focus will be resocialization in order to prepare to
return home.
In each phase there is a variety of treatment modules to suit the purpose of
the relevant phase. Some modules are standard, others are facultative. From
this complete set of treatment modules, a subset is selected that is tailored
to the specific needs of the participant. This individual program can be
adjusted during the course of the therapy.
There are a few small differences between our program and the Mannheim program.
Our program, for example, provides the possibility of family therapy, whereas
in Mannheim, the program allows for massages, physiotherapy and therapeutic
boxing. In Mannheim it is possible to consult a social worker about
resocialization.
Waiting list (WL): the participants randomised to the TAU-WL group, are allowed
to continue their current treatment with the referring therapist, except for
trauma therapy. For support, they are allowed to contact an independent person
who is not involved in the investigation. Participants of this group are
offered to start DBT-PE with priority after 12 weeks.
Study burden and risks
see E9
Borniastraat 34B
Leeuwarden 8934 AD
NL
Borniastraat 34B
Leeuwarden 8934 AD
NL
Listed location countries
Age
Inclusion criteria
Inclusion criteria are: (1) age 18-65 years old; (2) meeting the DSM-IV-defined diagnosis criteria of PTSD related to childhood abuse before the age of 18; (3) meeting the diagnostic criteria for at least one of the following conditions: eating disorder, major depressive disorder, substance abuse, or meeting *4 DSM-IV criteria for borderline personality disorder.
Exclusion criteria
Exclusion criteria for this research are a lifetime diagnosis of schizophrenia, the presence of psychotic symptoms, substance dependence, a body-mass-index * 17, antisocial personality disorder, intellectual disability defined by an IQ<70, medical conditions contradicting the exposure protocol (e.g. severe cardiovascular disorders). Individuals with ongoing self-harm or other high-risk behaviour are not excluded. However, for safety reasons, patients with a recent suicide attempt (in the last four months) will not be included.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL62862.099.17 |